Disseminated lung tuberculosis and tuberculosis meningoencephalitis after kidney transplantation
https://doi.org/10.23873/2074-0506-2018-10-3-217-221
Abstract
The epidemiological situation with tuberculosis in Russia continues to be strained. The issues of accurate diagnosis and treatment remain unsolved; these issues are particularly urgent for the patients after solid organ transplantation because of a higher risk of the disease development while on drug immunosuppression. This article has described the clinical case of a patient with a clinical presentation of disseminated pulmonary tuberculosis that emerged in a steroidresistant rejection. The issues of drug therapy and drug interactions with anti-tuberculosis and immunosuppressive agents have been discussed.
About the Authors
B. I. Yaremin
Samara State Medical University
Russian Federation
Russian Federation
Boris I. Yaremin - Associate Professor, Cand. Med. Sci., Head of the Samara Center for Organ and Tissue Transplantation.
89 Chapayevskaya St., Samara 443099
I. L. Tsygankov
Togliatti Tuberculosis Dispensary
Russian Federation
Russian Federation
34 Telegraph St., Togliatti 445013, Samara Region, Komsomolsky District
L. A. Baryshnikova
Postnikov Samara Regional Clinical Tuberculosis Dispensary
Russian Federation
Russian Federation
154 Novo-Sadovaya St., Samara 443068
A. A. Starostina
Samara State Medical University
Russian Federation
Russian Federation
89 Chapayevskaya St., Samara 443099
V. E. Aleksandrova
Samara State Medical University
Russian Federation
Russian Federation
89 Chapayevskaya St., Samara 443099
U. V. Maslikova
Samara State Medical University
Russian Federation
Russian Federation
89 Chapayevskaya St., Samara 443099
References
1. World Health Organization. Data of the Russian Federation on tuberculosis. 2016. Available at: https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_H_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=RU&outtype=html&LAN=RU (In Russian).
2. Agarwal S.K., Bhowmik D., Mahajan S., Bagchi S. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India. Transpl Infect Dis. 2017;19(1). PMID:27775825 DOI:10.1111/tid.12626
3. Al-Mukhaini S.M., Al-Eid H., Alduraibi F., et al. Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis. Ann Saudi Med. 2017;37(2):138–143. PMID:28377543 DOI:10.5144/0256-4947.2017.138
4. Barbouch S., Hajji M., Helal I., et al. Tuberculosis After Renal Transplant. Exp Clin Transplant. 2017;15(Suppl 1):200–203. PMID:28260468 DOI:10.6002/ect.mesot2016.P79
5. Edathodu J., Varghese B., Alrajhi A.A., et al. Diagnostic potential of interferongamma release assay to detect latent tuberculosis infection in kidney transplant recipients. Transpl Infect Dis. 2017;19(2). PMID:28170135 DOI:10.1111/tid.12675
6. Huaman M.A., Brawley R., Ashkin D. Multidrug-resistant tuberculosis in transplant recipients: Case report and review of the literature. Transpl Infect Dis. 2017;19(2). PMID:28166377 DOI:10.1111/tid.12672
7. Knoll B.M., Nog R., Wu Y., Dhand A. Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates. Infection. 2017;45(3):335–339. PMID:28276008 DOI:10.1007/s15010017-1004-5
Review
For citations:
Yaremin B.I., Tsygankov I.L., Baryshnikova L.A., Starostina A.A., Aleksandrova V.E., Maslikova U.V. Disseminated lung tuberculosis and tuberculosis meningoencephalitis after kidney transplantation. Transplantologiya. The Russian Journal of Transplantation. 2018;10(3):217-221. https://doi.org/10.23873/2074-0506-2018-10-3-217-221
Views:
1234
Email this article 